Newman Mark's Form 4 filing
Chemours Co (CC) · filed Dec 3, 2021
- Accession no.
- 0001627223-21-000051
- Filed
- Dec 3, 2021
- Trade date
- Dec 2, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.03M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Newman MarkCIK 0001524597 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Common Stock | MOption exerciseAcquired | +34,252 | $18.45 | +$631,949.4 | 179,710.58 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −34,252 | $29.94F3 | −$1,025,504.88 | 145,458.58 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Common Stock | MOption exerciseDisposed | −34,252 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Shares were sold in multiple transactions at prices ranging from $29.51 to $30.16.
Referenced by the price of 1 transaction in Table I.